Abstract

We have recently shown that genome-wide DNA hypomethylation induces genomic instability and tumors in animals ([ 1 ][1], [ 2 ][2]). Based on these results, we cautioned that long-term treatment with a demethylating agent such as 5-aza-2′deoxycytidine (5-aza-dC) may produce unwanted side effects

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.